Measles Review Postponed: Why the U. S. Needs More Time

The United States has pushed back a key meeting that will decide if the country still meets the “measles elimination” label, moving it from April to November. The panel, organized by the Pan American Health Organization, had invited U. S. officials to discuss whether recent outbreaks threaten that status, which means no continuous spread for a year. Health officials said they require additional time to sift through data before presenting it at the organization’s yearly gathering. If the U. S. were to lose its elimination title, it would be a tough blow for public health, because the country earned the designation in 2000 after decades of vaccination efforts and has kept it ever since.Many experts now think losing the status is likely, given that outbreaks have been happening every month since January 2025 and there were more cases last year than in any other two‑decade span. The delay also reflects the complexity of gathering evidence: The Centers for Disease Control must work with state and local agencies to track contacts, collect samples, and run genetic tests before the review. In short, the U. S. is taking extra steps to make sure its decision on measles elimination is based on solid evidence rather than a rushed judgment.